Literature DB >> 15728729

A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.

Mary Jane Potash1, Wei Chao, Galina Bentsman, Nicolae Paris, Manisha Saini, Jadwiga Nitkiewicz, Paula Belem, Leroy Sharer, Andrew I Brooks, David J Volsky.   

Abstract

We created a model of HIV-1 infection of conventional mice for investigation of viral replication, control, and pathogenesis. To target HIV-1 to mice, the coding region of gp120 in HIV-1/NL4-3 was replaced with that of gp80 from ecotropic murine leukemia virus, a retrovirus that infects only rodents. The resulting chimeric virus construct, EcoHIV, productively infected murine lymphocytes, but not human lymphocytes, in culture. Adult, immunocompetent mice were readily susceptible to infection by a single inoculation of EcoHIV as shown by detection of virus in splenic lymphocytes, peritoneal macrophages, and the brain. The virus produced in animals was infectious, as shown by passage in culture, and immunogenic, as shown by induction of antibodies to HIV-1 Gag and Tat. A second chimeric virus based on clade D HIV-1/NDK was also highly infectious in mice; it was detected in both spleen and brain 3 wk after tail vein inoculation, and it induced expression of infection response genes, MCP-1, STAT1, IL-1beta, and complement component C3, in brain tissue as determined by quantitative real-time PCR. EcoHIV infection of mice forms a useful model of HIV-1 infection of human beings for convenient and safe investigation of HIV-1 therapy, vaccines, and potentially pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728729      PMCID: PMC553332          DOI: 10.1073/pnas.0500649102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility.

Authors:  Megan K Patrick; James B Johnston; Christopher Power
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

2.  Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia: a new in vivo system for studying the postintegration phase of HIV replication.

Authors:  J Browning Paul; E J Wang; M Pettoello-Mantovani; C Raker; S Yurasov; M M Goldstein; J W Horner; J Chan; H Goldstein
Journal:  AIDS Res Hum Retroviruses       Date:  2000-03-20       Impact factor: 2.205

Review 3.  The macrophage response to HIV-1: Intracellular control of X4 virus replication accompanied by activation of chemokine and cytokine synthesis.

Authors:  Iqbal H Chowdhury; Galina Bentsman; Wonkyu Choe; Mary Jane Potash; David J Volsky
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

4.  Activation conditions determine susceptibility of murine primary T-lymphocytes to retroviral infection.

Authors:  A B Hagani; I Rivière; C Tan; A Krause; M Sadelain
Journal:  J Gene Med       Date:  1999 Sep-Oct       Impact factor: 4.565

5.  Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.

Authors:  M C Zink; G D Coleman; J L Mankowski; R J Adams; P M Tarwater; K Fox; J E Clements
Journal:  J Infect Dis       Date:  2001-09-10       Impact factor: 5.226

6.  Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes.

Authors:  M Canki; J N Thai; W Chao; A Ghorpade; M J Potash; D J Volsky
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1.

Authors:  O T Keppler; W Yonemoto; F J Welte; K S Patton; D Iacovides; R E Atchison; T Ngo; D L Hirschberg; R F Speck; M A Goldsmith
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

8.  Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells.

Authors:  Yong-Hui Zheng; Hai-Feng Yu; B Matija Peterlin
Journal:  Nat Cell Biol       Date:  2003-07       Impact factor: 28.824

9.  A chimeric human T-cell lymphotropic virus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells.

Authors:  Frédéric Delebecque; Karin Pramberger; Marie-Christine Prévost; Michel Brahic; Frédéric Tangy
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.

Authors:  Eleanor S Roberts; Michelle A Zandonatti; Debbie D Watry; Lisa J Madden; Steven J Henriksen; Michael A Taffe; Howard S Fox
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

View more
  80 in total

Review 1.  Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury.

Authors:  Ricky Maung; Kathryn E Medders; Natalia E Sejbuk; Maya K Desai; Rossella Russo; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-29       Impact factor: 4.147

Review 2.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

3.  Loss of neuronal integrity during progressive HIV-1 infection of humanized mice.

Authors:  Prasanta K Dash; Santhi Gorantla; Howard E Gendelman; Jaclyn Knibbe; George P Casale; Edward Makarov; Adrian A Epstein; Harris A Gelbard; Michael D Boska; Larisa Y Poluektova
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

Review 4.  Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency.

Authors:  Tamsin Garrod; Branka Grubor-Bauk; Stanley Yu; Tessa Gargett; Eric J Gowans
Journal:  Hum Vaccin Immunother       Date:  2014-11-19       Impact factor: 3.452

Review 5.  Type I Interferons in NeuroHIV.

Authors:  Victoria E Thaney; Marcus Kaul
Journal:  Viral Immunol       Date:  2018-09-27       Impact factor: 2.257

Review 6.  Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?

Authors:  Heather Carryl; Melanie Swang; Jerome Lawrence; Kimberly Curtis; Herman Kamboj; Koen K A Van Rompay; Kristina De Paris; Mark W Burke
Journal:  ACS Chem Neurosci       Date:  2015-06-19       Impact factor: 4.418

Review 7.  Translating the brain transcriptome in neuroAIDS: from non-human primates to humans.

Authors:  Jessica M Winkler; Amrita Datta Chaudhuri; Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2012-02-28       Impact factor: 4.147

8.  Frontline Science: c-Myc regulates P-selectin glycoprotein ligand-1 expression in monocytes during HIV-1 infection.

Authors:  Ryan Connor; Letitia D Jones; Xing Qiu; Juilee Thakar; Sanjay B Maggirwar
Journal:  J Leukoc Biol       Date:  2017-06-29       Impact factor: 4.962

9.  Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV.

Authors:  Jennifer L Kelschenbach; Manisha Saini; Eran Hadas; Chao-Jiang Gu; Wei Chao; Galina Bentsman; Jessie P Hong; Tomas Hanke; Leroy R Sharer; Mary Jane Potash; David J Volsky
Journal:  J Neuroimmune Pharmacol       Date:  2011-10-11       Impact factor: 4.147

10.  Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice.

Authors:  Saifur Rahman; Sharrón L Manuel; Zafar K Khan; Brian Wigdahl; Edward Acheampong; Frederic Tangy; Pooja Jain
Journal:  J Immunol       Date:  2010-04-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.